Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Rea, D, Gray, R, Bowden, S, Handley, K, Earl, H, Poole, C, Bates, T, Dewar, J, Raytor, Z, Lee, M
Formáid:	Conference item
Foilsithe / Cruthaithe:	2013

Míreanna comhchosúla

Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study
de réir: Dennis C. Sgroi, et al.
Foilsithe / Cruthaithe: (2022-12-01)

An Extraordinary New Toad (Bufo) ttom Costa Rica
de réir: Jay M Savage
Foilsithe / Cruthaithe: (2002-06-01)

Tamoxifen-independent recombination in the RIP-CreER mouse.
de réir: Yanmei Liu, et al.
Foilsithe / Cruthaithe: (2010-10-01)

Testing the untestable in language education /
de réir: Paran, Amos, et al.
Foilsithe / Cruthaithe: (c201)

Association Between the Gut Microbiota and Blood Pressure in a Population Cohort of 6953 Individuals
de réir: Joonatan Palmu, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
de réir: Liu Y, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model
de réir: Angel Pulido-Capiz, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
de réir: Coralie Poulard, et al.
Foilsithe / Cruthaithe: (2023-07-01)

A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
de réir: Weili He, et al.
Foilsithe / Cruthaithe: (2023-03-01)

USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
de réir: Ting Zhuang, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer
de réir: Angela Maselli, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging
de réir: Ying Li, et al.
Foilsithe / Cruthaithe: (2020-04-01)

A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER− cells via endoplasmic reticulum stress-induced apoptosis
de réir: Tinglin Yang, et al.
Foilsithe / Cruthaithe: (2024-02-01)

FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells
de réir: Lukasz Turczyk, et al.
Foilsithe / Cruthaithe: (2017-10-01)

δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer.
de réir: Shaocong Guo, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Five years of tamoxifen--or more?
de réir: Peto, R
Foilsithe / Cruthaithe: (1996)

Highlights of the first twenty years of the ERS, 1990-2010 past presidents of the ERS recall activities during their term of office
de réir: Donner Claudio F
Foilsithe / Cruthaithe: (2010-02-01)

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
de réir: Sheng-Li Lin, et al.
Foilsithe / Cruthaithe: (2010-02-01)

Video er TV er video
de réir: Susanna Neimann
Foilsithe / Cruthaithe: (1988-08-01)

ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups
de réir: Young Choi, et al.
Foilsithe / Cruthaithe: (2022-04-01)

NR4A1 Regulates Tamoxifen Resistance by Suppressing ERK Signaling in ER-Positive Breast Cancer
de réir: Yu Cheon Kim, et al.
Foilsithe / Cruthaithe: (2021-06-01)

circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells
de réir: Zheng Li, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models.
de réir: Wei Zou, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer
de réir: Sarra M. Rahem, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
de réir: Chindo Hicks, et al.
Foilsithe / Cruthaithe: (2012-02-01)

Untested natural medicines are big threats to health in China and Africa
de réir: Minghui Zhang
Foilsithe / Cruthaithe: (2020-07-01)

Peculiarities of gastroduodenal pathology in children in the families of parents with untested dyspepsia
de réir: V. V. Tsukanov, et al.
Foilsithe / Cruthaithe: (2019-07-01)

Diallel analysis and prediction of untested maize single cross hybrids
de réir: José Lidércio Matias Júnior, et al.
Foilsithe / Cruthaithe: (2019-02-01)

ASCLD statement on volume of untested sexual assault evidence kits
de réir: Laura Sudkamp, et al.
Foilsithe / Cruthaithe: (2020-01-01)

WHO-ERS train the trainer in smoking cessation: Three years' experience
de réir: Paraskevi Katsaounou
Foilsithe / Cruthaithe: (2019-10-01)

First preclinical SPECT/CT imaging and biodistribution of [165Er]ErCl3 and [165Er]Er-PSMA-617
de réir: Behrad Saeedi Saghez, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Polarity protein SCRIB interacts with SLC3A2 to regulate proliferation and tamoxifen resistance in ER+ breast cancer
de réir: Yasuhiro Saito, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
de réir: Hennekens, C, et al.
Foilsithe / Cruthaithe: (2006)

Deimplementing Untested Practices in Homecare Services: A Preobservational-Postobservational Design
de réir: Manon Guay, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Impact on arsenic exposure of a growing proportion of untested wells in Bangladesh
de réir: George Christine, et al.
Foilsithe / Cruthaithe: (2012-02-01)

Who Is Classified as Untestable on Brief Cognitive Screens in an Acute Stroke Setting?
de réir: Emma Elliott, et al.
Foilsithe / Cruthaithe: (2019-08-01)

Untested assumptions: psychological research and credibility assessment in legal decision-making
de réir: Jane Herlihy, et al.
Foilsithe / Cruthaithe: (2015-05-01)

ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
de réir: Vaishali Kumar, et al.
Foilsithe / Cruthaithe: (2021-01-01)

ER-Phagy and Its Role in ER Homeostasis in Plants
de réir: Yan Bao, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Stort er velgjort – eller småt er godt?
de réir: Gunnar Lind Haase Svendsen, et al.
Foilsithe / Cruthaithe: (2018-10-01)